Lilly Seeks Court Action Against Compounded Copies of Its Popular Weight-Loss Medications
Indianapolis-based pharmaceutical giant Eli Lilly and Co. has requested to join a lawsuit targeting manufacturers of compounded versions of its popular weight-loss drugs. The company alleges that these compounded versions might pose safety risks and infringe on its intellectual property rights. This legal move comes as the U.S. weight-loss drug market experiences significant growth, driven by increasing awareness and consumer demand for effective obesity treatments. The lawsuit, originally filed by the U.S. Department of Justice, seeks to halt the production and distribution of unauthorized compounded versions of drugs similar to Lilly’s FDA-approved offerings, including Mounjaro … Read more